相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam
Michael A. Rogawski
EPILEPSY & BEHAVIOR (2020)
Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop-seizure frequency
Kirsten Riber Bergmann et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
Simona Lattanzi et al.
CNS DRUGS (2020)
Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam
Taylor E. Savage et al.
EPILEPSY RESEARCH (2020)
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome A Randomized Clinical Trial
Ian Miller et al.
JAMA NEUROLOGY (2020)
The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights
Willian Lazarini-Lopes et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety
Simona Lattanzi et al.
DRUGS (2019)
Drug-drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program
Tyler E. Gaston et al.
EPILEPSY & BEHAVIOR (2019)
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
Lyndsey L. Anderson et al.
EPILEPSIA (2019)
Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome
S. Lattanzi et al.
DRUGS OF TODAY (2019)
Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
CEREBROVASCULAR DISEASES (2018)
Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
CNS DRUGS (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Orrin Devinsky et al.
NEUROLOGY (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut Syndrome: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
CNS DRUGS (2018)
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
DRUGS (2018)
Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis
Simona Lattanzi et al.
JOURNAL OF NEUROLOGY (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
Evan J. Hess et al.
EPILEPSIA (2016)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
Brivaracetam add-on for refractory focal epilepsy A systematic review and meta-analysis
Simona Lattanzi et al.
NEUROLOGY (2016)
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Alexandra L. Geffrey et al.
EPILEPSIA (2015)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
分享论文
